1 / 18

Thyroid & neurological disorders in pregnancy

Thyroid & neurological disorders in pregnancy. Dr.Roaa H. Gadeer MD. Physiology of thyroid function. TSH is released from anterior pituitary in 1-2 hrs cycle → thyroxin (T4) & triiodothyronin (T3).

wallis
Download Presentation

Thyroid & neurological disorders in pregnancy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Thyroid & neurological disorders in pregnancy Dr.Roaa H. Gadeer MD

  2. Physiology of thyroid function • TSH is released from anterior pituitary in 1-2 hrs cycle → thyroxin (T4) & triiodothyronin (T3). • 75% of T4 & T3 are bound to thyroid-binding globulin (TBG), the rest bound to albumin and transthyretin. • Free T4=0.04% and free T3=0.05%. • Iodine is trapped by the gland and converted to iodide to synthesize thyroglobulin. Each molecule carries 3-4 molecules of T4. • T3 is produced by peripheral deiodination of T4 and it is 3 times more potent than T4.

  3. Physiology of thyroid function • In pregnancy: - TBG ↑ in first 2 wks to reach a plateau at 20 wks due to ↑ Oestrogen level . - ↑ TBG → ↑ serum T4 & T3 with no change in free T4 & T3. • Iodine deficiency (↑GFR + fetal thyroid uptake) → ↑ thyroid gland uptake & enlargement (goitre). • hCG occupies TSH receptors → ↓TSH but it stimulates the gland → ↑ T4. • Placental conversion of T4 to T3 to prevent excess T4 & even low T4 level in late pregnancy.

  4. Fetal thyroid function • Firsttrimester: fetus needs maternal T4 for brain development. • Small amount of maternal T4 crosses placenta before 12 wks. • Maternal T3,T4 & TSH does not cross the placenta after 12 wks. • Fetal thyroid produces T3 & T4 after 10 wk’s gestation & reaches the adult levels at 36 wks. • Thyrotropin-releasing hormone (TRH) & iodine cross the placenta

  5. Thyroid function tests

  6. Aetiology & management • Iodine deficiency: - maternal gland has a greater affinity to iodide than placenta and fetus resulting in cretinism. • Fetal neocortex and basal ganglia are sensitive to iodine deficiency resulting in mental retardation. • Management: • Preconceptional iodine and up to second trimester. • Iodination of water, salt or flour

  7. Hyperthyroidism • Occurs in approximately 1 in 500 pregnancies. • In pregnancy it is due to Grave’s disease (90% to 95%).. • Graves' disease is an autoimmune disease results in production of thyroid-stimulating antibody (TSA), which mimics TSH and stimulates thyroid function and size increase. • Less common causes: toxic adenoma, toxic multinodular goiter, subacute thyroiditis, TSH producing pituitary tumor, metastatic follicular cell carcinoma, and painless lymphocytic thyroiditis. • Pregnancy-related causes: hyperemesis gravidarum, gestational trophoblastic disease (GTD), and struma ovarii

  8. Hyperthyroidism • signs and symptoms: tachycardia > 100 bpm, exophthalmos, thyromegaly, onycholysis (reflect the disease activity), and poor weight gain with good appetite. • Symptoms: fatigue and heat intolerance not useful (common in pregnancy). • laboratory test results: increase in serum T4 level and increase in the FT4 index • Complications: pre-eclampsia, thyroid storm, or CHF for the mother, and preterm labour and delivery, IUGR, and stillbirth

  9. HyperthyroidismTreatment • Is similar to non-pregnant women. • Radioactive iodine is containdicated. • Drugs: • propylthiouracil (PTU) or carbimazole and beta-blockers. • use the minimum dose as they cross the placenta causeing fetal hypothyroidism and goiter. • Both not teratogenic. Not contraindicate breastfeeding. • Both reduce TSH receptors antibodies titer → inhibition of T4 production. • PTU inhibits incorporation of iodine into tyrocine and peripheral conversion of T4 toT3.

  10. Hypothyroidism • hypothyroidism is uncommon (1%), because it is associated with infertility. • Causes: autoimmune Hashimoto’s thyroiditis (usaully), idiopathic myoedema, treatment of hyperthyroidism, type 1 diabetes is associated with an increased incidence of subclinical hypothyroidism during pregnancy. • Signs and Symptoms: Asymptomatic, weight gain, lethargy, weakness, cold sensitivity, hair loss, myxedematous changes, and dry skin. TSH level is increased; serum T4 level is low; and the FT4 index is decreased.

  11. Hypothyroidism • Treatment: • L-thyroxin, starting at 0.05 to 0.10 mg daily. • The dosage should be increased over several weeks the goal is normal laboratory values and resolve of the patient's symptoms. • A maximum dosage of 0.2 mg/d of L-thyroxin should not be exceeded . • TSH level alone can be followed to determine optimal dosing. • Complications: pre-eclampsia, IUGR, abruptio placentae, anaemia, postpartum haemorrhage, stillbirth, and cardiac dysfunction. • Fetal thyroid: not affected..

  12. Nodular thyroid disease • Evaluation: Ultrasound, and fine-needle aspiration or tissue biopsy • If thyroid carcinoma is found, surgical excision is the primary treatment and should not be postponed because of pregnancy

  13. Epilepsy • Incidence: 6/1000 pregnancy. • Seizure frequency may increase, decrease or no change (37%, 13% and 50% respectively). • Fetal anomalies ↑ in epileptic mother. • Anti-epileptic drugs (AED) responsible of most of fetal anomalies. • Control of seizures outweigh the risks • Polytherapy with (AED) caries more risks than monotherapy. • High doses of folic acid reduces fetal anomalies. • Lower doses of AED carry lower risk of fetal anomalies. • Patients not taking drugs or having regular seizures carry ↑ risk.

  14. Causes of epilepsy • Idiopathic epilepsy. • Intracranial infections: meningitis/encephalitis/brain abscess… • Vascular disease :cerebral infarction/eclampsia/sub-arachnoid haemorrhage. • Metabolic: liver & renal failure/hponat.glyc.calceamia….. • Drug toxicity: tricyclic antidepressant/local anesthesia (lignocain) • Secondary to specific cause: trauma/intracranial mass/Aps…

  15. Drugs used in epilepsy • Enzyme-inducing AED: • Phenobarbitone • Phenytoin. • carbamazepine • Non-enzyme-inducing AED: • valproate. • Gabapentin. • Lamotrigine. • clonazepam

  16. Management of epilepsy • Pre-pregnancy counseling: • Stop AED in patients having no seizure for 2 years. • Use single AED with low dose. • Folic acid 5 mg/day (sp. Carbamazepine & valproate). • Antenatal management: • Screening for fetal anomalies. • Oral vitamin K 10 mg/day from 36 wks onwards to prevent hemorrhage. • Women adviced to take shower rather than bath. • If storoid is given for obstetric indication it should be within 48 hrs (24 mg dexamethazone 24 hrs apart)

  17. Management of epilepsy • Intrapartum care: • Vaginal delivery is advised. • Seizures ↑: sleep disturbance, ↓ drug intake and absorption & hyperventilation (make sure that the drugs has been took). • Seizures during labour are best controlled with IV benzodiazepines (diazepam/clonazepam) • Postpartum care: • Encourage breastfeeding (rare neonatal effects). • A single 1 mg of vitamin K to the neonate is advisable. • Contraception: enzyme-inducing AED reduce the efficacy so 50 ug oestrogen, reduce the free interval to 5-6 days, depo-provera is used every 10 wks & mirena is ideal (progesterone not affected enzyme-inducing AED ).

  18. thanks

More Related